Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment
Clinical trial NCT01428531 · COMPLETED
Trial details
- NCT number
- NCT01428531
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-01-01
- Primary completion
- 2015-06-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.